FrançaisProtagonist Therapeutics, Inc. (PTGX): financial analysis & fundamentals
📈 See the interactive version (live chart) →
Valuation & profitability
| Metric | Value | What it means |
|---|---|---|
| P/E (price / earnings) | — | The higher, the more growth the market expects. |
| Forward P/E | — | On next year's expected earnings. Lower than current P/E = rising earnings. |
| PEG (P/E ÷ growth) | — | Below 1 = cheap given growth; above 2 = expensive. |
| Net margin | — | Share of revenue that ends up as profit. |
| Revenue growth | — | Pace of revenue growth. |
| Price-to-book | — | Price relative to book value. |
| Market cap | — | Total market value of the company. |
| Dividend yield | — | No dividend currently. |
📊 Open the interactive Protagonist Therapeutics, Inc. page (charts, live news) →
Frequently asked questions
Is Protagonist Therapeutics, Inc. stock expensive?
Protagonist Therapeutics, Inc. has a P/E of — (forward P/E —) and a PEG of —. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.
What is Protagonist Therapeutics, Inc.'s net margin?
Protagonist Therapeutics, Inc.'s net margin is about — — the share of revenue that ends up as net profit.
What is Protagonist Therapeutics, Inc.'s revenue?
Protagonist Therapeutics, Inc.'s income statement is detailed on this page.
What is Protagonist Therapeutics, Inc.'s market cap?
Protagonist Therapeutics, Inc. (PTGX) has a market cap of about —.
Does Protagonist Therapeutics, Inc. pay a dividend?
No, Protagonist Therapeutics, Inc. does not currently pay a dividend (it reinvests earnings).
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.